share_log

信達生物:董事會召開日期

INNOVENT BIO: DATE OF BOARD MEETING

HKEX ·  Aug 14 16:47

Summary by Futu AI

信達生物製藥有限公司宣布將於2024年8月28日(星期三)召開董事會會議。會議的主要目的是考慮及批准截至2024年6月30日止六個月的中期業績報告及其發佈,同時也將考慮是否建議派發中期股息。該會議將由公司主席兼執行董事俞德超博士主持。
信達生物製藥有限公司宣布將於2024年8月28日(星期三)召開董事會會議。會議的主要目的是考慮及批准截至2024年6月30日止六個月的中期業績報告及其發佈,同時也將考慮是否建議派發中期股息。該會議將由公司主席兼執行董事俞德超博士主持。
Innovent bio pharmaceutical co., ltd. announced that it will hold a board of directors meeting on August 28, 2024 (Wednesday). The main purpose of the meeting is to consider and approve the interim performance report for the six months ending June 30, 2024, as well as its release. The board will also consider whether to recommend the distribution of interim dividends. The meeting will be chaired by Dr. Yu Dechao, the company's chairman and executive director.
Innovent bio pharmaceutical co., ltd. announced that it will hold a board of directors meeting on August 28, 2024 (Wednesday). The main purpose of the meeting is to consider and approve the interim performance report for the six months ending June 30, 2024, as well as its release. The board will also consider whether to recommend the distribution of interim dividends. The meeting will be chaired by Dr. Yu Dechao, the company's chairman and executive director.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.